Jun Chen
17Patents
3h-index
40Co-inventors
60Inventor score
Filing activity: Jul 14, 1997 → Mar 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9415050B2 | Methods for the treatment of HER2 amplified cancer | Human Necessities | 15 | Active |
| US10913094B2 | Multi-unit rotary system and method for storage, intelligent sorting and picking of express parcels | Performing Operations; Transporting | 5 | Active |
| US11242395B2 | Anti-CD137 molecules and use thereof | Chemistry; Metallurgy | 3 | Active |
| US11859003B2 | Method for treating cancer using anti-CD137 antibody | Chemistry; Metallurgy | 2 | Active |
| US9724349B2 | Methods for the treatment of HER2 amplified cancer | Human Necessities | 1 | Active |
| US10888544B2 | Methods for treating Gaucher disease | Human Necessities | 0 | Active |
| US11639396B2 | Antibody binding to a linker peptide | Chemistry; Metallurgy | 0 | Active |
| US5968771A | Global ischemia induced gene | Chemistry; Metallurgy | 0 | Expired |
| US11878963B2 | Semi synthetic method for dihydroquercetin | Chemistry; Metallurgy | 0 | Active |
| US12129310B2 | Materials and methods for enhanced linker targeting | Chemistry; Metallurgy | 0 | Active |
| US11192943B2 | Protein binding to fibronectin B domain | Physics | 0 | Active |
| US12144822B2 | Mir-17˜92 as therapeutic or diagnostic target of motor neuron (MN) degeneration diseases | Chemistry; Metallurgy | 0 | Active |
| US9073995B2 | Bladder cancer tumor marker, antibody and use thereof | Physics | 0 | Active |
| US10611830B2 | Human antibody against ED-B domain of fibronectin and uses thereof | Physics | 0 | Active |
| US10016434B2 | Methods for the treatment of HER2 amplified cancer | Human Necessities | 0 | Active |
| US11970529B2 | Protein binding to fibronectin B domain | Physics | 0 | Active |
| US12378319B2 | Anti-CD137 molecules and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.